PDS Biotechnology Corporation — Quarterly Financial Data (NASDAQ:PDSB) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

ニュース

PDS Biotech amends Phase 3 trial to add accelerated approval path

PDS Biotechが前立腺がん研究で9.6ヶ月の無増悪生存期間を報告

PDS Biotech reports 9.6-month progression-free survival in prostate cancer study

PDSバイオテック、がん免疫療法PDS0101の特許を取得

PDS Biotech secures patent for cancer immunotherapy PDS0101

PDS Biotechの株価、FDAとの会議で迅速承認への道が開け急上昇

PDS Biotech stock soars after FDA meeting provides accelerated approval path

PDSバイオテック、第3相がん治験の改訂プロトコルを提出

PDS Biotech submits amended protocol for phase 3 cancer trial

PDS Biotech secures new patent for cancer immunotherapy in Japan

PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why

PDSバイオテク、迅速承認経路の協議のためFDA会議を確保